PlainPharmaWatch

CMS Open Payments · Program Year 2024

Digital Diagnostics Inc.

Digital Diagnostics Inc. reported $10,172,234.40 across General Payments, Research, and Ownership to 27 physicians and teaching hospitals across 46 transactions.

See the rankings → How this is sourced
$10.2M Top 10% payer
All-tracks total
46 Below-median volume
Transactions
27 Below-median reach
Recipients
−$37.4K
General Payments vs PY2023

Digital Diagnostics Inc. reported $10,172,234.40 across all CMS Open Payments tracks (General + Research + Ownership) to 27 physicians and teaching hospitals in Program Year 2024 - ranking #172 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $54,399.55, averaging $376.7K per recipient.

How Digital Diagnostics Inc.'s $10.2M all-tracks total breaks down

Digital Diagnostics Inc.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

39/100

Total payments

A

100/100

Transaction volume

F

10/100

Physician reach

F

10/100

Payment type diversity

F

37/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer digital-diagnostics-inc Digital Diagnostics Inc.

$10.2M · #172/1,925 · 0.1% industry · PY2024

  • TOT $10.2M
  • RANK #172
  • SHARE 0.1%
  • TXN 46
  • RCP 27
  • CAT 3
  • GEN $54.4K
  • ΔGEN −$37.4K
  • TOP1 73.5%
  • PY 2024

Volume peers

Nearest volume peer: Medacta USA, Inc. ($10.2M)

ACADIA Pharmaceuticals Inc$10.2MDigital Diagnostics Inc. (th…$10.2MMedacta USA, Inc.$10.2MNational Marrow Donor Program$10.2MOsteoCentric Technologies, I…$10.1M
All-tracks payment totals near Digital Diagnostics Inc. (CMS Open Payments PY2024)

Digital Diagnostics Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Digital Diagnostics Inc.'s CMS-reported General Payments decreased by $37.4K (−40.7%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: DIGITAL DIAGNOSTICS INC.PY2023: DIGITAL DIAGNOSTICS INC.PY2024: Digital Diagnostics Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$91.8KPY2024$54.4K
PY2023
$91,775.43
PY2024
$54,399.55

What the Data Shows for Digital Diagnostics Inc.

CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Digital Diagnostics Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.

"Consulting Fee" leads the 3-category general-payment breakdown below at $52.3K (96.0% of General Payments, 22 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 3 types of general payments, Digital Diagnostics Inc.'s largest category was "Consulting Fee" at $52.3K - 96.0% of General Payments.

How Digital Diagnostics Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$52.3K2. Compensation for Faculty …$1.8K3. Food and Beverage$391.98
Payment Type Amount Transactions
Consulting Fee $52.3K 22
Compensation for Faculty or Speaker (Medical Education) $1.8K 3
Food and Beverage $391.98 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $54,399.55 (100.0%) of $54,399.55 in this company's General Payments records across 5 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Digital Diagnostics Inc.

The five named recipients with the highest reported General Payments from this company

Aaron B Roller$40.0KJames Folk$12.3KKathleen Provanzana$1.8KLinda Lam$260.54Matt T ROSENBERG$131.44
  1. 1

    Aaron B Roller

    $40,000.00 across 11 reported transactions

  2. 2

    James Folk

    $12,250.00 across 11 reported transactions

  3. 3

    Kathleen Provanzana

    $1,757.57 across 3 reported transactions

  4. 4

    Linda Lam

    $260.54 across 1 reported transactions

  5. 5

    Matt T ROSENBERG

    $131.44 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Digital Diagnostics Inc.'s spend rank (#172 of 1,925, top 9% by spend) and concentration rank (#267 of 1,838, top 15% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.

00.30.50.81.15863.75931.459996066.66134.3Total payments ($M)Concentration (HHI, 0-10,000)
Digital Diagnostics Inc. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Digital Diagnostics Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Digital Diagnostics Inc..

Vertical Orthopaedics, Inc.

HHI 5923

TheraMicro, Inc.

HHI 5918

ReShape Lifesciences Inc.

HHI 5891

Rebiotix Inc.

HHI 5889

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Digital Diagnostics Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Digital Diagnostics Inc. ranks #172 of 1,925 by all-tracks total payments, led by "Consulting Fee".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Digital Diagnostics Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.